CBD element | Facilitators | Barriers | |
---|---|---|---|
Medicines | o Centralised dispensing simplifies distribution process. | o Quality assurance processes must be fulfilled by HCPs prior to “last mile” distribution; o Stock-outs of medicines cripples CBD models; o Non-collected medicines cannot be re-dispensed. | |
Human resources | Community Health Workers | o Positive, close relationships with patients which can facilitate active follow-up when necessary. | o Not able to conduct quality assurance processes. |
HCPs | o Missing medicines from patient-ready parcels can be dispensed manually by the HCP at the CBD site. | o General shortage of HCPs undermine sustainability of deploying them to CBD sites. | |
Informal providers | o Demand-driven therefore likely to suit beneficiary needs. | o No governmental oversight which could lead to financial exploitation of patients; o no accountability to professional statutory body which could compromise quality of pharmaceutical services. | |
Infrastructure and logistics | o Government vehicles available for transportation of medicines for some models. | o Poor transport systems for CHWs causing delays and posing security and environmental risks to medicines; o Availability of venues not always guaranteed. | |
Patient (population)’s engagement with CBD models | o Positive patient-patient; patient-provider relationships; o Some patients knowledgeable about their treatment regimen and proactive in addressing medicine-related concerns. | o Stigma associated with HIV still a reality. |